Summary

● The company has a good ESG score relative to its sector, according to Refinitiv.


Strengths

● The company's profit outlook over the next few years is a strong asset.

● The stock, which is currently worth 2022 to 0.22 times its sales, is clearly overvalued in comparison with peers.

● The company's share price in relation to its net book value makes it look relatively cheap.

● The company has a low valuation given the cash flows generated by its activity.

● Sales forecast by analysts have been recently revised upwards.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Analyst opinion has improved significantly over the past four months.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.


Weaknesses

● According to forecast, a sluggish sales growth is expected for the next fiscal years.

● The company does not generate enough profits, which is an alarming weak point.

● The company is not the most generous with respect to shareholders' compensation.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.